Related Experiment Videos
Intrathecal interferon in subacute sclerosing panencephalitis
D Maimone1, L M Grimaldi, G Incorpora
1Department of Neurology, University of Catania, Italy.
Acta Neurologica Scandinavica
|September 1, 1988
Summary
Subacute sclerosing panencephalitis (SSPE) patients showed temporary neurological and cognitive improvements with alpha-interferon (IFN) treatment. Benefits waned post-treatment, with mild side effects noted.
Area of Science:
- Neurology
- Immunology
Background:
- Subacute sclerosing panencephalitis (SSPE) is a severe, progressive neurological disease.
- Current treatments for SSPE are limited, necessitating research into novel therapeutic approaches.